Suppr超能文献

香草酸的抗氧化和抗炎潜力可改善亚砷酸钠诱导的小鼠肾毒性。

Antioxidant and anti-inflammatory potential of vanillic acid improves nephrotoxicity induced by sodium arsenite in mice.

作者信息

Khodayar Mohammad Javad, Shirani Maryam, Shariati Saeedeh, Khorsandi Layasadat, Mohtadi Shokooh

机构信息

Toxicology Research Center, Medical Basic Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

Department of Toxicology, Faculty of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

出版信息

Int J Environ Health Res. 2024 Dec 9:1-11. doi: 10.1080/09603123.2024.2439452.

Abstract

This study examined the potential of vanillic acid (VA) to protect against renal oxidative stress and inflammation caused by sodium arsenite (SA) in mice. Mice were assigned to five groups: control, VA (100 mg/kg), SA (50 ppm in drinking water for 8 weeks), and SA + VA (50 and 100 mg/kg orally in the 7th and 8th weeks). After the experiment was ended, the Mice were sacrificed and serum and renal tissue samples were collected for additional assessments. Treatment with VA suppressed SA-induced increase in blood urea nitrogen and creatinine in the serum. Furthermore, renal histological damage induced by SA administration was ameliorated with VA treatment. Also, the increase in the level of lipid peroxidation marker (thiobarbituric acid reactive substances) along with the reduction in total thiol levels and the diminished activities of antioxidant enzymes (catalase, superoxide dismutase, and glutathione peroxidase) in the renal tissue of SA-treated mice were effectively reversed following treatment with VA. The results exhibited that the VA-treated groups (50 and 100 mg/kg) mitigated the elevation of inflammatory markers in kidney tissue (tumor necrosis factor-α and nitric oxide) in SA-exposed mice. Our research findings indicate that VA could be a potential therapeutic agent for the management of SA-associated nephrotoxicity.

摘要

本研究考察了香草酸(VA)对小鼠体内由亚砷酸钠(SA)引起的肾脏氧化应激和炎症的防护潜力。将小鼠分为五组:对照组、VA组(100毫克/千克)、SA组(饮用水中含50 ppm,持续8周)以及SA + VA组(在第7周和第8周口服50和100毫克/千克)。实验结束后,处死小鼠并采集血清和肾脏组织样本用于进一步评估。VA处理可抑制SA诱导的血清中血尿素氮和肌酐的升高。此外,VA处理改善了SA给药所致的肾脏组织学损伤。而且,在SA处理的小鼠肾脏组织中,脂质过氧化标志物(硫代巴比妥酸反应性物质)水平的升高以及总硫醇水平的降低和抗氧化酶(过氧化氢酶、超氧化物歧化酶和谷胱甘肽过氧化物酶)活性的减弱,在VA处理后均得到有效逆转。结果显示,VA处理组(50和100毫克/千克)减轻了SA暴露小鼠肾脏组织中炎症标志物(肿瘤坏死因子-α和一氧化氮)的升高。我们的研究结果表明,VA可能是一种用于管理SA相关肾毒性的潜在治疗剂。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验